Literature DB >> 9421545

Cognitive side effects of medications.

K J Meador1.   

Abstract

Iatrogenically induced cognitive deficits are common with pharmacological therapy. The deficits may range from gross encephalopathy with delirium to subtle subjective alterations (e.g., mood and perception of well being). The risks are increased for certain drug types, polypharmacy, the elderly, and patients with dementia or metabolic abnormalities. This review examines methodological concerns and the neuropsychological data on cognitive side effects across a variety of commonly used medicines in clinical practice.

Entities:  

Mesh：

Year:  1998        PMID： 9421545     DOI： 10.1016/s0733-8619(05)70371-6

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  15 in total

1.  Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status.

Authors:  Ing-Britt Holmquist; Bengt Svensson; Peter Höglund
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

Review 2.  Guidelines for Feature Matching Assessment of Brain-Computer Interfaces for Augmentative and Alternative Communication.

Authors:  Kevin M Pitt; Jonathan S Brumberg
Journal:  Am J Speech Lang Pathol       Date:  2018-08-06       Impact factor: 2.408

3.  Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.

Authors:  Joanie Thelen; Valeriy Zvonarev; Sarah Lam; Crystal Burkhardt; Sharon Lynch; Jared Bruce
Journal:  Mo Med       Date:  2021 May-Jun

4.  A clinical screening protocol for the RSVP Keyboard brain-computer interface.

Authors:  Melanie Fried-Oken; Aimee Mooney; Betts Peters; Barry Oken
Journal:  Disabil Rehabil Assist Technol       Date:  2013-09-23

5.  Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture: a retrospective, population-based study.

Authors:  Jorma Panula; Juha Puustinen; Pekka Jaatinen; Tero Vahlberg; Pertti Aarnio; Sirkka-Liisa Kivela
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia.

Authors:  S Ozgocmen; T Yoldas; A Kamanli; H Yildizhan; R Yigiter; O Ardicoglu
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

7.  Brain-computer interface with language model-electroencephalography fusion for locked-in syndrome.

Authors:  Barry S Oken; Umut Orhan; Brian Roark; Deniz Erdogmus; Andrew Fowler; Aimee Mooney; Betts Peters; Meghan Miller; Melanie B Fried-Oken
Journal:  Neurorehabil Neural Repair       Date:  2013-12-26       Impact factor: 3.919

Review 8.  Quality of life in adults with brain tumors: current knowledge and future directions.

Authors:  Raymond Liu; Margaretta Page; Karla Solheim; Sherry Fox; Susan M Chang
Journal:  Neuro Oncol       Date:  2008-11-10       Impact factor: 12.300

9.  Study protocol for the recreational stimulation for elders as a vehicle to resolve delirium superimposed on dementia (Reserve For DSD) trial.

Authors:  Ann M Kolanowski; Donna M Fick; Mark S Litaker; Linda Clare; Doug Leslie; Malaz Boustani
Journal:  Trials       Date:  2011-05-11       Impact factor: 2.279

10.  Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.

Authors:  Pekka Rapeli; Carola Fabritius; Hely Kalska; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.